Alpha Methyl Phenylethylamines

Alpha Methyl Phenylethylamines

1416 bookmarks
Newest
Clinical Translation Services | Intertranslations
Clinical Translation Services | Intertranslations
Regulatory complexities, patient access, increased competition, new technology - there are so many obstacles that pharmaceutical companies are facing when conducting a clinical trial.
·intertranslations.com·
Clinical Translation Services | Intertranslations
Therapy Notes Software | Lower Admin Time | SimplePractice
Therapy Notes Software | Lower Admin Time | SimplePractice
Streamline your workflow and spend more time with your clients. Try our therapy notes software for mental health professionals with a FREE 30-days trial.
·simplepractice.com·
Therapy Notes Software | Lower Admin Time | SimplePractice
https://medinfo.boehringer-ingelheim.com/us/medical-research-funding?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1v9lXJjFRUFKzOsw6_4n--vUnJ3sg_6j865oMrSnTjOvv_JfeK8mkgaAvPHEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/medical-research-funding?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1v9lXJjFRUFKzOsw6_4n--vUnJ3sg_6j865oMrSnTjOvv_JfeK8mkgaAvPHEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
·medinfo.boehringer-ingelheim.com·
https://medinfo.boehringer-ingelheim.com/us/medical-research-funding?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1v9lXJjFRUFKzOsw6_4n--vUnJ3sg_6j865oMrSnTjOvv_JfeK8mkgaAvPHEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/medical-research-funding?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1vG58e6GFyigWN-d0DnKfoxxQ3ma8fBHS5MEr0GqmRZj-FnzzBzPewaAlf8EALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/medical-research-funding?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1vG58e6GFyigWN-d0DnKfoxxQ3ma8fBHS5MEr0GqmRZj-FnzzBzPewaAlf8EALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
·medinfo.boehringer-ingelheim.com·
https://medinfo.boehringer-ingelheim.com/us/medical-research-funding?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1vG58e6GFyigWN-d0DnKfoxxQ3ma8fBHS5MEr0GqmRZj-FnzzBzPewaAlf8EALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/research-development/clinical-trial-investigator-form?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1sw1qRzsEKkGdye1YsjCY5m0yckXEmOuEB-IsQRzjfXzPTGDnvZTrsaAiGdEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/research-development/clinical-trial-investigator-form?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1sw1qRzsEKkGdye1YsjCY5m0yckXEmOuEB-IsQRzjfXzPTGDnvZTrsaAiGdEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
·medinfo.boehringer-ingelheim.com·
https://medinfo.boehringer-ingelheim.com/us/research-development/clinical-trial-investigator-form?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1sw1qRzsEKkGdye1YsjCY5m0yckXEmOuEB-IsQRzjfXzPTGDnvZTrsaAiGdEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/therapy-area-resources?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1vNxqfcjN_Wqt_1o5WPG7mQ6tOuDuR5X9QAJhHQr9cA43mcQZ3OWYIaAiW5EALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/therapy-area-resources?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1vNxqfcjN_Wqt_1o5WPG7mQ6tOuDuR5X9QAJhHQr9cA43mcQZ3OWYIaAiW5EALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
·medinfo.boehringer-ingelheim.com·
https://medinfo.boehringer-ingelheim.com/us/therapy-area-resources?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1vNxqfcjN_Wqt_1o5WPG7mQ6tOuDuR5X9QAJhHQr9cA43mcQZ3OWYIaAiW5EALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/research-development/clinical-trial-investigator-form?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1u5T32rHBtWRyvkVi-pkW1675OY_I31ZkyMWo5MoBixhZn0XjkINPkaAmBqEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
https://medinfo.boehringer-ingelheim.com/us/research-development/clinical-trial-investigator-form?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1u5T32rHBtWRyvkVi-pkW1675OY_I31ZkyMWo5MoBixhZn0XjkINPkaAmBqEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
·medinfo.boehringer-ingelheim.com·
https://medinfo.boehringer-ingelheim.com/us/research-development/clinical-trial-investigator-form?cid=cpc%3AGoogleAds%3A3w_bipi_gads_search_us_en_traffic_generic_hcp_clinical-trials-investigator_g%3A%3AClinical+Investigator_p_kwd-clinical+investigator&gclid=Cj0KCQjw2a6wBhCVARIsABPeH1u5T32rHBtWRyvkVi-pkW1675OY_I31ZkyMWo5MoBixhZn0XjkINPkaAmBqEALw_wcB&gclsrc=aw.ds&s_kwcid=AL%216545%213%21538415498841%21p%21%21g%21%21clinical+investigator
The Sourcebook for Clinical Research
The Sourcebook for Clinical Research
A single trial is complex, with numerous regulations, administrative processes, medical procedures, deadlines and specific protocol instructions to follow. And yet, there has existed no single-volume, comprehensive clinical research reference manual for investigators, medical institutions, and national and international research personnel to keep on the shelf as a ready reference to navigate through trial complexities and ensure compliance with U.S. Federal Regulations and ICH GCP until The Sourcebook for Clinical Research. An actionable, step-by-step guide through beginning to advanced topics in clinical research with forms, templates and checklists to download from a companion website, so that study teams will be compliant and will find all the necessary tools within this book. Additionally, the authors developed Display Posters for Adverse Events Plus Reporting and Medicare Coverage Analysis that can be purchased separately here: https://www.elsevier.com/books-and-journals/book-companion/9780128162422/order-display-posters. Moreover, The Sourcebook for Clinical Research contains clear information and guidance on the newest changes in the industry to keep seasoned investigators and staff current and compliant, in addition to providing detailed information regarding the most complex topics. This book serves as a quick, actionable, off-the-shelf resource to keep by your side at the medical clinic. Makes vital trial conduct information easy to understand and instructs on how to practically apply current Federal regulations and Good Clinical Practice (ICH GCP) Offers extensive guidance that is crucial for guaranteeing compliance to clinical research regulations during each step of the clinical research process Provides up-to-date and extensive coverage of beginning to advanced topics, and, step-by-step actions to take during exceptional circumstances, including compassionate use, emergency use, human subjects protections for vulnerable populations, and federal audits Furnishes a detailed clinical research Glossary, and a comprehensive Appendix containing ready-to-use forms, templates, and checklists for clinical trial personnel to download and begin using immediately. Written for the fast-paced clinic environment with action steps and forms in the book to respond to a research subject’s needs urgently and compliantly
·google.com·
The Sourcebook for Clinical Research
Emergency departments prove fertile ground for smoking cessation success
Emergency departments prove fertile ground for smoking cessation success
The Cessation of Smoking Trial in the Emergency Department (COSTED) study demonstrates that a brief intervention including e-cigarette starter kits can significantly help smokers in emergency departments quit, offering a new avenue to tackle smoking rates and associated health inequalities.
·news-medical.net·
Emergency departments prove fertile ground for smoking cessation success
The effectiveness of intervention with board games: a systematic review - BioPsychoSocial Medicine
The effectiveness of intervention with board games: a systematic review - BioPsychoSocial Medicine
To examine the effectiveness of board games and programs that use board games, the present study conducted a systematic review using the PsycINFO and PubMed databases with the keywords “board game” AND “trial;” in total, 71 studies were identified. Of these 71 studies, 27 satisfied the inclusion criteria in terms of program content, intervention style, and pre–post comparisons and were subsequently reviewed. These 27 studies were divided into the following three categories regarding the effects of board games and programs that use board games: educational knowledge (11 articles), cognitive functions (11 articles), and other conditions (five articles). The effect sizes between pre- and post-tests or pre-tests and follow-up tests were 0.12–1.81 for educational knowledge, 0.04–2.60 and − 1.14 – − 0.02 for cognitive functions, 0.06–0.65 for physical activity, and − 0.87 – − 0.61 for symptoms of attention-deficit hyperactivity disorder (ADHD). The present findings showed that, as a tool, board games can be expected to improve the understanding of knowledge, enhance interpersonal interactions among participants, and increase the motivation of participants. However, because the number of published studies in this area remains limited, the possibility of using board games as treatment for clinical symptoms requires further discussion.
·link.springer.com·
The effectiveness of intervention with board games: a systematic review - BioPsychoSocial Medicine
(IRBs) and Protection of Human Subjects
(IRBs) and Protection of Human Subjects
Under FDA regulations, an Institutional Review Board is group that has been formally designated to review and monitor biomedical research involving human subjects.
·fda.gov·
(IRBs) and Protection of Human Subjects
Technical Review Committees | NCII
Technical Review Committees | NCII
The Center's six Technical Review Committees are made up of national experts in academic and/or behavioral assessments and interventions and have strong methodological expertise.
·intensiveintervention.org·
Technical Review Committees | NCII
Institutional Review Boards and Health Services Research Data Privacy: A Workshop Summary
Institutional Review Boards and Health Services Research Data Privacy: A Workshop Summary
The Institute of Medicine (IOM) and the Committee on the Role of Institutional Review Boards in Health Services Research Data Privacy Protection hosted a workshop on March 13–14, 2000, to gather and to exchange information on the protection of human subjects in health services research (HSR). HSR examines the impact of the organization, financing and management, of health care services, on the access to, delivery, cost, outcomes and quantity of those services. The benefits of such studies include increased understanding of the effects of changing parts of the health care system, such as whether a change in the reimbursement policy for a particular class of drug has any effect on the health or quality of life of the participants. The major risk in such research is not physical harm, but risk resulting from improper disclosure of personal information, that is, a breach of confidentiality. Confidentiality can be protected by limiting access to data and strengthening protections of data handling. However, HSR can be conducted only if researchers have access to data. Thus, data privacy and data access are objectives that have to be balanced.
·ncbi.nlm.nih.gov·
Institutional Review Boards and Health Services Research Data Privacy: A Workshop Summary
Exceptions to the rule of informed consent for research with an intervention - BMC Medical Ethics
Exceptions to the rule of informed consent for research with an intervention - BMC Medical Ethics
Background In specific situations it may be necessary to make an exception to the general rule of informed consent for scientific research with an intervention. Earlier reviews only described subsets of arguments for exceptions to waive consent. Methods Here, we provide a more extensive literature review of possible exceptions to the rule of informed consent and the accompanying arguments based on literature from 1997 onwards, using both Pubmed and PsycINFO in our search strategy. Results We identified three main categories of arguments for the acceptability of a consent waiver: data validity and quality, major practical problems, and distress or confusion of participants. Approval by a medical ethical review board always needs to be obtained. Further, we provide examples of specific conditions under which consent waiving might be allowed, such as additional privacy protection measures. Conclusions The reasons legitimized by the authors of the papers in this overview can be used by researchers to form their own opinion about requesting an exception to the rule of informed consent for their own study. Importantly, rules and guidelines applicable in their country, institute and research field should be followed. Moreover, researchers should also take the conditions under which they feel an exception is legitimized under consideration. After discussions with relevant stakeholders, a formal request should be sent to an IRB.
·link.springer.com·
Exceptions to the rule of informed consent for research with an intervention - BMC Medical Ethics
The effectiveness of intervention with board games: a systematic review - BioPsychoSocial Medicine
The effectiveness of intervention with board games: a systematic review - BioPsychoSocial Medicine
To examine the effectiveness of board games and programs that use board games, the present study conducted a systematic review using the PsycINFO and PubMed databases with the keywords “board game” AND “trial;” in total, 71 studies were identified. Of these 71 studies, 27 satisfied the inclusion criteria in terms of program content, intervention style, and pre–post comparisons and were subsequently reviewed. These 27 studies were divided into the following three categories regarding the effects of board games and programs that use board games: educational knowledge (11 articles), cognitive functions (11 articles), and other conditions (five articles). The effect sizes between pre- and post-tests or pre-tests and follow-up tests were 0.12–1.81 for educational knowledge, 0.04–2.60 and − 1.14 – − 0.02 for cognitive functions, 0.06–0.65 for physical activity, and − 0.87 – − 0.61 for symptoms of attention-deficit hyperactivity disorder (ADHD). The present findings showed that, as a tool, board games can be expected to improve the understanding of knowledge, enhance interpersonal interactions among participants, and increase the motivation of participants. However, because the number of published studies in this area remains limited, the possibility of using board games as treatment for clinical symptoms requires further discussion.
·bpsmedicine.biomedcentral.com·
The effectiveness of intervention with board games: a systematic review - BioPsychoSocial Medicine
Community Review Boards | UAMS Translational Research Institute
Community Review Boards | UAMS Translational Research Institute
A Community Review Board is a onetime guidance session for health researchers interested in working in a community setting. A TRI CE team member recruits community members to serve as experts who will provide feedback on various aspects of a proposed or on‐going research project, including the design, intervention, communication…
·tri.uams.edu·
Community Review Boards | UAMS Translational Research Institute
Institutional Review Boards and Social Science Research
Institutional Review Boards and Social Science Research
Report addressing the government’s rules for protecting human beings who are the subjects of social science research. It offers suggestions for the improvement of IRB practices and recommendations.
·aaup.org·
Institutional Review Boards and Social Science Research
Drug Utilization Review Board
Drug Utilization Review Board
The Georgia Drug Utilization Review Board (DURB) was established under the authority of Section 1903(3) A of the Omnibus Budget Reconciliation Act of 1990 (OBRA). The Board promotes patient safety through an increased review and awareness of outpatient prescribed drugs.
·dch.georgia.gov·
Drug Utilization Review Board